Trademark search for:

BYDUREON SYSPEN

EXPIRED USPTO USPTO

No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.

Trademark records may change over time. For the most up-to-date trademark status, domain availability, and social handle checks, run a live search.

Live search · Most up-to-date results

Also check across:

USPTO Filing History

Key events recorded for this trademark application

2012-06-20 — Application filed
2012-06-23 — Application filed
2012-06-28 — Application filed
2012-10-05 — Assigned to examiner
2012-10-10 — Examiners amendment -written
2012-10-10 — Approved for pub - principal register
2012-10-10 — Examiners amendment e-mailed
2012-10-10 — Notification of examiners amendment e-mailed
2012-10-10 — Examiner's amendment entered
2012-10-24 — Assigned to lie
2012-10-24 — Law office publication review completed
2012-10-31 — Assignment of ownership not updated automatically
2012-11-07 — Notification of notice of publication e-mailed
2012-11-27 — Published for opposition
2012-11-27 — Official gazette publication confirmation e-mailed
2013-01-22 — Noa e-mailed - sou required from applicant
2013-05-29 — Attorney/dom.rep.revoked and/or appointed
2013-05-29 — Teas revoke/app/change addr of atty/dom rep received
2013-08-26 — Application abandoned
2013-08-26 — Application abandoned
2013-08-26 — Final status recorded

Owner Information

Amylin Pharmaceuticals, Inc.
San Diego , CA

Correspondent

Marilyn F. Kelly Bristol-Myers Squibb Company
P.O. Box 4000
Trademarks Dept., Mailstop D33-05
Princeton, NJ 08648-4000

Filing Details

Filing Date:
2012-06-20

Status Date:
2013-08-26

Category:
Pharmaceuticals

Filing Year:
2012

Disclaimer: This page is informational only and does not constitute legal advice. Trademark availability depends on jurisdiction, usage, and legal interpretation.